Cited by 72Epigenetics and DNA MethylationNeurotransmitter Receptor Influence on BehaviorGenetic Associations and Epidemiology

Epigenetic signature of MAOA and MAOB genes in mental disorders

Ziegler, Christiane, Domschke, Katharina·2018·Journal of Neural Transmission

Abstract

Epigenetic processes such as DNA methylation are considered key mechanisms at the crossroads between genetics and environment in the etiology of mental disorders. The monoamine oxidases A and B (MAOA/MAOB) are prime candidates for the investigation into the role of DNA methylation in mental disorders, given their pivotal role in the metabolism of monoamines and as pharmacological targets of potent antidepressant drugs such as tranylcypromine, phenelzine or moclobemide. The present mini-review aims at summarizing and critically discussing the growing body of the literature supporting a role of DNA methylation of the MAOA gene promoter/exon I/intron I region and its interaction with environmental factors in several mental disorders, i.e., anxiety disorders, depression, posttraumatic stress disorder, substance use disorder, conduct disorder/antisocial personality disorder, borderline personality disorder and schizophrenia, as well as some pilot data on MAOB methylation in smokers and patients with borderline personality disorder. Furthermore, first evidence for MAOA methylation to be involved in treatment response prediction and as a potential mechanistic correlate of fear extinction is presented. Altered MAOA gene DNA methylation emerges as a possible pathogenetically relevant epigenetic mechanism in mental disorders. Given robust replication and further functional characterization, MAOA methylation patterns might serve as a peripheral biomarker of disease risk and treatment response informing preventive and personalized therapeutic approaches in the future.

Integrity signals

Registry

Crossref · 10.1007/s00702-018-1929-6

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human MAOA methylation is positively correlated with the percentage of recently experienced positive life events, while relative hypomethylation is associated with the experience of negative life events and a number of mental disorders including panic disorder, depression and substance abuse.

    “human MAOA methylation has been found to be positively correlated with the percentage of recently experienced positive life events, while relative hypomethylation has been associated with the experience of negative life events (Domschke et al., 2012) and a number of mental disorders including panic disorder, depression and substance abuse (for review, see Ziegler & Domschke, 2018).”
  • The effects of genes on behavior may also be modified by sex-specific factors such as the levels of testosterone and Y-chromosome genes.

    “the effects of genes on behavior may also be modified by sex-specific factors such as the levels of testosterone and Y-chromosome genes [140, 141].”

    From Genetics of child aggression, a systematic review (2024) · cites this paper as [141]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ziegler, C., & Domschke, K.
Affiliations
University of Freiburg (DE)
Corresponding author
Domschke, Katharina
Venue
Journal of Neural Transmission
Published
2018-09-21
Volume
125
Issue
11
Pages
1581-1588
ISSN
  • 0300-9564 (ISSN-L)
  • 1435-1463
OpenAlex
W2892238887
Cited by
72
References
38
Citations by year
2026: 3 · 2025: 8 · 2024: 6 · 2023: 13 · 2022: 14 · 2021: 16 · 2020: 9 · 2019: 2 · 2018: 1
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neural Transmission (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (SFB-TRR-58, C02, SFB-TRR-58, Z02)
  • German Ministry of Research and Education, BMBF (01EE1402F, PROTECT-AD, P5)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
monoamine oxidase A, monoamine oxidase B, monoamine oxidase, DNA methylation, epigenetics, mental illness, gene-environment interaction, anxiety disorders, depression, post-traumatic stress disorder, substance use disorders, conduct disorder, antisocial personality disorder, borderline personality disorder, schizophrenia, smoking, treatment response prediction, fear extinction, biomarkers
MeSH terms
Mental Disorders, Humans, Monoamine Oxidase, Promoter Regions, Genetic, DNA Methylation, Genetic Predisposition to Disease, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review